Maurizio Costabile

Prof. Maurizio Costabile

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CHCharles S. T. Hii
Charles S. T. Hii
ZHZhi H. Huang
Zhi H. Huang
ABAndrea Bilney
Andrea Bilney
MCMaurizio Costabile
Maurizio Costabile
AMAndrew W. Murray
Andrew W. Murray
AFAntonio Ferrante
Antonio Ferrante
Although it is well appreciated that arachidonic acid, a second messenger molecule that is released by ligand-stimulated phospholipase A2, stimulates a wide range of cell types, the mechanisms that mediate the actions of arachidonic acid are still poorly understood. We now report that arachidonic acid stimulated the appearance of dual-phosphorylated (active) p38 mitogen-activated protein kinase as detected by Western blotting in HeLa cells, HL60 cells, human neutrophils, and human umbilical vein endothelial cells but not Jurkat cells. An increase in p38 kinase activity caused by arachidonic acid was also observed. Further studies with neutrophils show that the stimulation of p38 dual phosphorylation by arachidonic acid was transient, peaking at 5 min, and was concentration-dependent. The effect of arachidonic acid was not affected by either nordihydroguaiaretic acid, an inhibitor of the 5-, 12-, and 15-lipoxygenases or by indomethacin, an inhibitor of cyclooxygenase. Arachidonic acid also stimulated the phosphorylation and/or activity of the extracellular signal-regulated protein kinase and of c-jun N-terminal kinase in a cell-type-specific manner. An examination of the mechanisms through which arachidonic acid stimulated the phosphorylation/activity of p38 and extracellular signal-regulated protein kinase in neutrophils revealed an involvement of protein kinase C. Thus, arachidonic acid stimulated the translocation of protein kinase C α, βI, and βII to a particulate fraction, and the effects of arachidonic acid on mitogen-activated protein kinase phosphorylation/activity were partially inhibited by GF109203X, an inhibitor of protein kinase C. This study is the first to demonstrate that a polyunsaturated fatty acid causes the dual phosphorylation and activation of p38.

1 September 2016 in Cellular Signalling
Verified
Journal Article
Closed access
MPMelissa R. Pitman
Melissa R. Pitman
MCMaurizio Costabile
Maurizio Costabile
Stuart PitsonStuart Pitson
Stuart Pitson

29 March 2010 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
MCMaurizio Costabile
Maurizio Costabile
The classical pathway is activated by antibody and culminates in target cell lysis. The CH50 assay provides a measure of the ...


30 June 2022 in Blood
Verified
Journal Article
Open access
PDF file
ALAlexander C. Lewis
Alexander C. Lewis
VPVictoria S. Pope
Victoria S. Pope
MTMelinda N. Tea
Melinda N. Tea
MLManjun Li
Manjun Li
GNGus O. Nwosu
Gus O. Nwosu
Stuart PitsonStuart Pitson
Stuart Pitson
Inducing cell death by the sphingolipid ceramide is a potential anticancer strategy, but the underlying mechanisms remain poorly defined. In this study, triggering an accumulation of ceramide in acute myeloid leukemia (AML) cells by inhibition of sphingosine kinase induced an apoptotic integrated stress response (ISR) through protein kinase R–mediated activation of the master transcription factor ATF4. This effect led to transcription of the BH3-only protein Noxa and degradation of the prosurvival Mcl-1 protein on which AML cells are highly dependent for survival. Targeting this novel ISR pathway, in combination with the Bcl-2 inhibitor venetoclax, synergistically killed primary AML blasts, including those with venetoclax-resistant mutations, as well as immunophenotypic leukemic stem cells, and reduced leukemic engraftment in patient-derived AML xenografts. Collectively, these findings provide mechanistic insight into the anticancer effects of ceramide and preclinical evidence for new approaches to augment Bcl-2 inhibition in the therapy of AML and other cancers with high Mcl-1 dependency.

Verified
Journal Article
Open access
PDF file
LDLeigh Donnellan
Leigh Donnellan
CYClifford Young
Clifford Young
BSBradley S. Simpson
Bradley S. Simpson
MAMitchell Acland
Mitchell Acland
VDVarinderpal S. Dhillon
Varinderpal S. Dhillon
PDPermal Deo
Permal Deo
Methylglyoxal (MGO) is a highly reactive cellular metabolite that glycates lysine and arginine residues to form post-translational modifications known as advanced glycation end products. Because of their low abundance and low stoichiometry, few studies have reported their occurrence and site-specific locations in proteins. Proteomic analysis of WIL2-NS B lymphoblastoid cells in the absence and presence of exogenous MGO was conducted to investigate the extent of MGO modifications. We found over 500 MGO modified proteins, revealing an over-representation of these modifications on many glycolytic enzymes, as well as ribosomal and spliceosome proteins. Moreover, MGO modifications were observed on the active site residues of glycolytic enzymes that could alter their activity. We similarly observed modification of glycolytic enzymes across several epithelial cell lines and peripheral blood lymphocytes, with modification of fructose bisphosphate aldolase being observed in all samples. These results indicate that glycolytic proteins could be particularly prone to the formation of MGO adducts.